MEI Pharma, Inc.
3611 Valley Centre Drive, Suite 500
San Diego, CA 92130
May 14, 2020
VIA EDGAR TRANSMISSION
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Office of Life Sciences
| Re: | MEI Pharma, Inc. |
| Registration Statement on Form S-3 |
| Filed May 7, 2020 |
| File No. 333-238056 |
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, MEI Pharma, Inc. (the “Company”), hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-238056), so that such registration statement may become effective at 4:00 p.m. (Washington, D.C. time) on May 18, 2020, or as soon as practicable thereafter.
| MEI PHARMA, INC. | ||||
| By: | /s/ Brian G. Drazba | |||
| Name: Brian G. Drazba Title: Chief Financial Officer | ||||